logo

Mannkind Corp. (MNKD)



Trade MNKD now with
  Date
  Headline
1/6/2020 8:15:54 AM MannKind Partner Biomm Receive Written Notice From CMED Approving Proposed Price Of Afrezza In Brazil
11/21/2019 9:09:13 AM MannKind Adds Tony Hooper To Its Board
9/19/2019 9:01:29 AM MannKind Presents Data From One-year Study Of Afrezza Inhalation Powder
1/16/2019 4:31:52 PM MannKind Announces Direct Purchase Insulin Program Providing Afrezza For As Low As $4 A Day
12/19/2018 11:58:54 PM MannKind Announces Pricing Of Public Offering Of 26.67 Mln Shares And Warrants For A Combined Purchase Price Of $1.50
11/1/2018 8:06:00 AM MannKind Q3 Net Loss $24.2 Mln Or $0.16/Shr Vs Loss $32.9 Mln Or $0.31/Shr Last Year
10/16/2018 6:01:03 AM United Therapeutics, MannKind Announce Closing Of Pending Worldwide Exclusive License And Collaboration Agreement
10/4/2018 9:02:10 AM MannKind Presents Positive Afrezza STAT Study Clinical Data
10/3/2018 9:03:10 AM MannKind Presents New Scientific Data At 54th Annual Meeting Of The European Association For The Study Of Diabetes
9/24/2018 9:05:05 AM MannKind Completes Cohort 1 And Opens Enrollment For Cohort 2 Of Afrezza Safety And Pharmacokinetics Study In Pediatric
9/4/2018 6:01:19 AM United Therapeutics, MannKind Enter Exclusive Licensing, Collaboration Agreement For Pulmonary Hypertension Products
  
 
>